JAKARTA – PT Galva Technologies Tbk (GLVA), an electronic device distributor, branches out to medical equipment trading in order to drive organic growth of the company in the future. Maria Fransiska, Corporate Secretary of Galva Technologies, announced the plan in the information disclosure quoted Tuesday (21/6).
“In the upcoming Extraordinary General Shareholders Meeting, the company will ask for approval regarding the product diversification to medical equipment, in which we will add more variants to products that will hit the market and enhance collaboration with our strategic partners,” Fransiska explained.
The company has conducted a feasibility study through the Public Appraisal Office of Doli Siregar and Partners as the independent partner officially listed in Financial Services Authority (OJK). The feasibility study result shows the financial and human resources adequacy of the company in respect to said plan.
As of December 2021, GLVA recorded sales of IDR 1.74 trillion, squeezing out the current year’s profit of IDR 39.69 billion. The sales number came from the business solution division of IDR 427.57 billion, the document solution division of IDR 113.06 billion, and the IT distribution segment of IDR 1.20 trillion. (LK/ZH)